MedPath

BREVIBLOC PREMIXED INJECTION

BREVIBLOC PREMIXED INJECTION

Approved
DIN Number

02309238

Drug Class

Human

Market Date

Sep 12, 2008

Company
HC

baxter corporation

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02309238
AIG Number0123418003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C07AB09 ESMOLOL
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification24:24.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

ESMOLOL HYDROCHLORIDEActive
Strength: 10 MG / ML
Monograph: ESMOLOL HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.